AbbVie sees hit to Humira sales from European competition
Go back to AbbVie sees hit to Humira sales from European competition| AbbVie (NYSE: ABBV) | Delayed: 249.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $249.91 | 52 Week High | $68.12 | |||
| Open | $249.91 | 52 Week Low | $50.71 | |||
| Day High | $249.91 | P/E | 54.21 | |||
| Day Low | $249.91 | EPS | $4.61 | |||
| Volume | 1,045 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 363.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $363.62 | 52 Week High | $176.85 | |||
| Open | $363.62 | 52 Week Low | $133.64 | |||
| Day High | $363.62 | P/E | 54.76 | |||
| Day Low | $363.62 | EPS | $6.64 | |||
| Volume | 359 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 198.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $198.91 | 52 Week High | $333.65 | |||
| Open | $198.91 | 52 Week Low | $223.02 | |||
| Day High | $198.91 | P/E | 25.47 | |||
| Day Low | $198.91 | EPS | $7.81 | |||
| Volume | 76 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 259.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.10 | 52 Week High | $126.07 | |||
| Open | $259.10 | 52 Week Low | $94.28 | |||
| Day High | $259.10 | P/E | 53.87 | |||
| Day Low | $259.10 | EPS | $4.81 | |||
| Volume | 2,081 | |||||
| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
| NOVEN PHARMACEUTIC (NASDAQ: NOVN) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $23.79 | |||
| Open | $10.12 | 52 Week Low | $13.73 | |||
| Day High | $0.09 | P/E | 0.09 | |||
| Day Low | $0.09 | EPS | $1.05 | |||
| Volume | 1,574,031 | |||||

